NutropinAq<sup>®</sup> [somatropin]

NutropinAq<sup>®</sup> Pen


NutropinAq® is a liquid formulation of a recombinant human growth hormone administered using the NutropinAq® Pen.

Active substance

somatropin, recombinant DNA origin, Escherichia coli

NutropinAq® is indicated for:

  • Long-term treatment of children with growth failure due to inadequate endogenous growth hormone secretion.
  • Long-term treatment of girls from 2 years old with growth failure associated with Turner syndrome.
  • Treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation.
  • Replacement of endogenous growth hormone in adults with growth hormone deficiency of either childhood or adult-onset etiology. Growth hormone deficiency should be confirmed appropriately prior to treatment.